Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and ranking of recurrent neo-epitopes in cancer.

BMC medical genomics - 27 Nov 2019

Blanc Eric, Holtgrewe Manuel, Dhamodaran Arunraj, Messerschmidt Clemens, Willimsky Gerald, Blankenstein Thomas, Beule Dieter

Abstract excerpt

BACKGROUND: Immune escape is one of the hallmarks of cancer and several new treatment approaches attempt to modulate and restore the immune system's capability to target cancer cells. At the heart of the immune recognition process lies antigen presentation from somatic mutations. These neo-epitopes are emerging as attractive targets for cancer immunotherapy and new strategies for rapid identification of relevant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Computational Biology
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes

Share to Genes, MHC Class I

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 31775766
DOI: 10.1186/s12920-019-0611-7
PMCID: PMC6882202

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and ranking of recurrent neo-epitopes in cancer.PMID 31775766Read ↗

Identification and Ranking of Recurrent Neo-Epitopes in CancerSemantic proximity Read ↗

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy TargetsSemantic proximity Read ↗

Discovery of prevalent, clinically actionable tumor neoepitopes via integrated biochemical and cell-based platformsSemantic proximity Read ↗

The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.Semantic proximity Read ↗

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.Semantic proximity Read ↗

Predicting T cell recognition of MHC class I restricted neoepitopesSemantic proximity Read ↗

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.Semantic proximity Read ↗

Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)Semantic proximity Read ↗

Identification of public neoantigens with broad HLA class I coverage as candidates for off-the-shelf cancer vaccine development in colorectal cancer.Semantic proximity Read ↗

The immunogenic potential of recurrent cancer drug resistance mutations: an <i>in silico</i> studySemantic proximity Read ↗

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer ImmunotherapySemantic proximity Read ↗

Computational Prediction and Validation of Tumor-Associated Neoantigens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.